Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Daix (France), New York City (New York, Etats Unis), le 17 décembre 2024 – Inventiva (Euronext Paris and...
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA...
Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million Inventiva secures €21.4 million leading to completion of...
Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros Inventiva lève...
Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on...
Résultats des votes de l’Assemblée Générale Mixte des actionnaires – 11 décembre 2024 Daix (France), New York City (New York, Etats-Unis), le 11 décembre 2024 – Inventiva (Euronext Paris et Nasdaq...
Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024 Daix (France), New York City (New York, United States), December 11, 2024 – Inventiva (Euronext Paris and...
Daix (France), New York City (New York, United States), December 11, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...
Inventiva publie ses informations financières du 3ème trimestre 2024¹ Trésorerie et équivalents de trésorerie à 13,9 millions d’euros au 30 septembre 2023.Chiffre d’affaires de 1,3 millions...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -2.24215246637 | 2.23 | 2.25 | 2.155 | 10219 | 2.18830702 | DE |
| 4 | -0.17 | -7.23404255319 | 2.35 | 2.48 | 2 | 20959 | 2.26928678 | DE |
| 12 | 0.68 | 45.3333333333 | 1.5 | 3.2 | 1.434 | 53529 | 2.42472969 | DE |
| 26 | -0.52 | -19.2592592593 | 2.7 | 3.2 | 1.434 | 41954 | 2.30939364 | DE |
| 52 | -1.92 | -46.8292682927 | 4.1 | 4.44 | 1.434 | 47807 | 2.90281279 | DE |
| 156 | -9.58 | -81.462585034 | 11.76 | 12.18 | 1.434 | 54477 | 3.81820298 | DE |
| 260 | -1.6 | -42.328042328 | 3.78 | 16.16 | 1.434 | 64298 | 7.06681779 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
